Johns Hopkins
Washington, District of Columbia, United States
Aliyah Pabani, M.D., M.P.H. is an Assistant Professor of Oncology at the Sidney Kimmel Comprehensive Cancer at Johns Hopkins in the Upper Aerodigestive Cancer Division (UAD). She is Co-Director of the Immune-Related (IR) Toxicity Team.
Dr. Pabani completed Internal Medicine residency and Medical Oncology fellowship at the University of Alberta after which she pursued an Advanced Thoracic Oncology fellowship at Columbia University. She also received a Masters of Public Health from Harvard University.
Dr. Pabani treats thoracic and head and neck cancers and conducts clinical and translational research in immunotherapy-related adverse events and immunotherapy in squamous cell cancers.
Current Cancer Immunotherapy Landscape and the Future
Monday, October 27, 2025
4:00 PM – 4:30 PM Central Time
Disclosure(s): Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Partner Therapeutics: Advisory Board (Terminated, April 8, 2025); Regeneron: Consultant (Ongoing), Grant/Research Support (Ongoing)
